MedTrace Logo

Evaluation of Optical System in the Treatment of - Dry Eye Disease

NCT05741398 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-06-27

No results posted yet for this study

Summary

Single-center, Prospective, Open Label, with Before-After Study Design, to evaluate the safety and efficacy of the optical system in the treatment of dry eye disease.

Conditions

  • Dry Eye Syndromes

Interventions

DEVICE

VR system by Demaod

non-invasive light pulse generated by a non-contacting device for the treatment of the symptoms of dry eyes and MDG

Sponsors & Collaborators

  • Demaod Ltd

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-11-01
Completion
2023-12-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05741398 on ClinicalTrials.gov